Ji et al. [170] demonstrated the involvement of ERBB2 (HER2, receptor tyrosine kinase group of epidermal growth factor receptors), BIRC5 (survivin, baculoviral inhibitor of apoptosis repeat-containing 5), and CASP3 in the process of quercetin-paclitaxel synergy-induced apoptosis in ovarian cancer. Here, ERBB2 is linked to ovarian carcinoma.